Press release
Key Factor Supporting Veterinary CRO And CDMO Market Development in 2025: Increasing Animal Healthcare Investments
Veterinary CRO And CDMO
How Large Will the Veterinary CRO And CDMO Market Size By 2025?
In recent times, the veterinary cro and cdmo market has experienced robust growth. The market size is projected to increase from $6.97 billion in 2024 to $7.55 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. The historical growth has been driven by factors such as compliance with regulations, the worldwide expansion of the animal health market, enhanced drug development for livestock, and increased outsourcing by pharmaceutical firms.
How Big Is the Veterinary CRO And CDMO Market Size Expected to Grow by 2029?
The market size of veterinary CRO and CDMO is forecasted to witness substantial expansion in the upcoming years. By 2029, it is set to reach $10.74 billion, with a CAGR of 9.2%. The projected growth during the forecast period could be a result of wider acceptance of precision medicine, emphasis on preventive healthcare, epidemiological tracking, readiness for emergencies, and the increasing intricacy of veterinary therapeutics. Key trend shifts throughout this period are expected to involve R&D outsourcing, tech integration, collaborations and partnerships, adoption of sustainable practices in production, and veterinary services' digital transformation.
View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report
Which Key Market Drivers Powering Veterinary CRO And CDMO Market Expansion and Growth?
The expansion of the veterinary CRO and CDMO market is anticipated to be fueled by rising investments in animal healthcare. This surge in investment is credited to the heightened awareness of animal health's significance and the growing demand for veterinary services and merchandise, all of which contribute to the development of this market. As indicated in a report by the American Pet Products Association (APPA), a non-profit entity from the U.S. advocating for pet ownership and the pet products industry, pet care expenditure in the U.S. experienced an increase from USD 123.6 billion in 2021 to 136.8 billion in 2022, as of October 2023. As a result, the veterinary CRO and CDMO market is projected to grow due to these bolstered investments in animal healthcare.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Veterinary CRO And CDMO Market?
Product innovation is proving to be a significant trend in the veterinary CRO and CDMO marketplace. To maintain their market position, companies in these sectors are honing in on novel product development. Case in point, Vetio - an American Contract Development and Manufacturing Organization (CDMO) specializing in animal health services - was recognized by the European Patent Office (EPO) and the United States Patent Office (USPTO) in June 2022. The recognition was for a Starch-Free Soft Chew developed specifically for veterinary use. Vetio's Soft Chew Technology platform, purpose-built for animal health, is perfectly engineered to administer one or multiple active components in a premium dosage form fit for veterinary pharmaceutical usage. Fusing innovative composition and manufacturing techniques, Vetio's process avoids starch and surplus water, making it an excellent choice for active components sensitive to moisture.
What Are the Emerging Segments in the Veterinary CRO And CDMO Market?
The veterinary cro and cdmo market covered in this report is segmented -
1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications
Subsegments:
1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization
2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting
3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services
4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance
5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp
Who Are the Global Leaders in the Veterinary CRO And CDMO Market?
Major companies operating in the veterinary cro and cdmo market include Eurofins Scientific SE, Pharmaceutical Product Development Inc., Syneos Health Inc., Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited., Inotiv Inc., Promega Corporation, Aenova Group, Sai Life Sciences Ltd., Taconic Bioscience Inc., Avid Bioservices Inc., Frontage Laboratories Inc., Angion Biomedica Corp., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Triveritas Ltd., Cebiphar, Ondax Scientific UK Ltd., Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l.
Which are the Top Profitable Regional Markets for the Veterinary CRO And CDMO Industry?
North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12080
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Factor Supporting Veterinary CRO And CDMO Market Development in 2025: Increasing Animal Healthcare Investments here
News-ID: 4102866 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for CRO
Contract Research Organization (CRO) Research: China CRO market size is projecte …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Contract Research Organization (CRO)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few…
Global Veterinary CRO & CDMO Market Size & Trends
According to a new market research report published by Global Market Estimates, the global veterinary CRO & CDMO market is expected to grow at a CAGR of 9.1% from 2023 to 2028.
The growing awareness regarding the importance of animal health and welfare has led to increased investments in veterinary pharmaceutical research and development. This awareness is driven by the rising concern for the well-being of pets, livestock, and animals used…
Global Contract Research Organization (CRO) Services Market
According to a new market research report published by Global Market Estimates, the Global Contract Research Organization (CRO) Services Market is expected to grow at a CAGR of 10.2% from 2023 to 2028.
The growth of the contract research organization (CRO) Services Market is fuelled by factors including the rising preference for outsourcing clinical trials, increasing investments in research and development by pharmaceutical and biopharmaceutical companies, the growing complexities in drug…
Contract Research Organization (CRO) Services Market - Efficiency, Expertise, Ex …
Newark, New Castle, USA: The "Contract Research Organization (CRO) Services Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Contract Research Organization (CRO) Services Market: https://www.growthplusreports.com/report/contract-research-organization-cro-services-market/7630
This latest report…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Pracedo Promote Ellie Copp To CRO
Pracedo, a Mashfrog Group company that provides Salesforce consultancy and digital transformation to charities, NGOs, and enterprise customers, promotes Ellie Copp to Chief Revenue Officer.
Pracedo announced Ellie Copp as its new Chief Revenue Officer (CRO). Ellie joined Pracedo in 2019 and most recently held the position of Sales and Marketing Director. As CRO, she will continue to lead the commercial teams by overseeing all revenue-generating activities as Pracedo continues…
